Before revision: There are a number of new anti-TB medications that are currently in the developmental stage that are directed to treat drug resistant strains; a few of these drugs are PA-824 , OPC-67683 , and R207910 , all of which are in Phase II of development.
After revision: (now pretomanid)(now delamanid)(now bedaquiline)There are a number of new anti-TB medications that are currently in the developmental stage that are directed to treat drug resistant strains; a few of these drugs are PA-824 , OPC-67683 , and R207910 , all of which are in Phase II of development.